The medical technology company Micropos Medical reports decreased revenue in the fourth quarter compared with the same period the year before. The operating loss increased.Revenue fell 17.6 percent to SEK 1.4 million (1.7).Operating result was SEK -6.2 million (-5.0). Result after tax was SEK -6.1 million (-4.6). Earnings per share amounted to SEK -0.04 (-0.03)."Since last spring, a handful of Swedish patients have asked for our help to establish contact with hospitals that treat using ASBRT and the Raypilot System. They have themselves found facts about the advantages of ASBRT, not least in comparison with surgery. Unfortunately, they are met with passivity from Swedish healthcare and penalized for wanting to avoid side effects and thereby be able to maintain their quality of life after completed treatment. They choose to pay for their treatment themselves. I hope that Swedish and Scandinavian healthcare will soon open their eyes and ears to both SBRT and the crucial ASBRT", writes CEO Richard Forsberg. Micropos Medical, SEK mQ4-2025Q4-2024ChangeNet sales1.41.7-17.6%Operating result-6.2-5.0Net result-6.1-4.6Earnings per share, SEK-0.04-0.03